This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Market Update: Potash Ridge Cashes In With $20 Million IPO

The potash market was shaken up on Wednesday when Canada's Potash Ridge (TSX: PRK) generated $20 million through the initial public offering (IPO) of its common shares.

Most of the money will go toward developing the company's Utah-based Blawn Mountain sulphate of potash (SOP) project. The 11,550-acre project is close to the infrastructure required for its construction and operation, and is made up of four areas that include surface-mineable alunite, which is rich in SOP. Most importantly, Potash Ridge's website notes, the project is supported by both the municipality and the state.

The company anticipates that completion of a prefeasibility study and issuance of a NI 43-101 technical report for the project will both occur in the second quarter of 2013.

Additionally, as part of the IPO, Potash Ridge entered into a private placement with Sprott Resource Partnership. That leaves Sprott with 16,144,746 common shares of Potash Ridge, according to a  statement released by Sprott.

Potash Ridge's positive news indicates that perhaps favorable 2013 forecasts from major potash market players like Russia's Uralkali and Potash Corporation of Saskatchewan (TSX:POT) are not unrealistic.

Market Update: Potash Ridge Cashes in with $20 Million IPO from Potash Investing News

null

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,099.31 -104.06 -0.57%
S&P 500 2,098.53 -9.25 -0.44%
NASDAQ 4,969.5730 -10.3280 -0.21%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs